Cargando…
TMPRSS4 as a Poor Prognostic Factor for Triple-Negative Breast Cancer
Triple-negative breast cancer (TNBC) is characterized by the lack of immunohistochemical staining for estrogen receptors (ER), progesterone receptors (PR), and lack of overexpression or amplification of human epidermal growth factor receptor 2 (HER2). Our aim was to investigate the expression of tra...
Autores principales: | Cheng, Daye, Kong, Hong, Li, Yunhui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3742265/ https://www.ncbi.nlm.nih.gov/pubmed/23857060 http://dx.doi.org/10.3390/ijms140714659 |
Ejemplares similares
-
Triple negative breast cancer – prognostic factors and survival
por: Ovcaricek, Tanja, et al.
Publicado: (2010) -
Decreased Wnt5a Expression is a Poor Prognostic Factor in Triple-Negative Breast Cancer
por: Zhong, ZhenBin, et al.
Publicado: (2016) -
Serum Vascular Endothelial Growth Factor (VEGF-C) as a Diagnostic and Prognostic Marker in Patients with Ovarian Cancer
por: Cheng, Daye, et al.
Publicado: (2013) -
Downregulation of TMPRSS4 Enhances Triple-Negative Breast Cancer Cell Radiosensitivity Through Cell Cycle and Cell Apoptosis Process Impairment
por: Assani, Ganiou, et al.
Publicado: (2019) -
TMPRSS4 as an emerging potential poor prognostic factor for solid tumors: A systematic review and meta-analysis
por: Zeng, Ping, et al.
Publicado: (2016)